Annals of Hematology

, Volume 90, Issue 7, pp 843–844

Acute megakaryoblastic leukemia AML FAB-M7 in a patient 15 years after kidney transplantation

Letter to the Editor


  1. 1.
    Cohen D, Galbraith C (2003) General health management and long-term care of the renal transplant recipient. Am J Kidney Dis 38(Suppl 6):S10–S24Google Scholar
  2. 2.
    Gorschlüter M, Glasmacher A, Risse F, Klein B, Klehr HU, Mezger J (1997) Successful induction and consolidation therapy of acute myeloid leukaemia in a renal allograft recipient. Nephrol Dial Transplant 12:593–595PubMedCrossRefGoogle Scholar
  3. 3.
    Subar M, Gucalp R, Benstein J, Williams G, Wiernik PH (1996) Acute leukaemia following renal transplantation. Med Oncol 13:9–13PubMedCrossRefGoogle Scholar
  4. 4.
    Thalhammer-Scherrer R, Wieselthaler G, Knoebl P, Schwarzinger I, Simonitsch I, Mitterbauer G, Berlakovich GA, Mannhalter C, Haas OA, Mayer G, Muehlbacher F, Wolner E, Klepetko W, Lechner K, Jaeger U (1999) Post-transplant acute myeloid leukemia (PT-AML). Leukemia 13:321–326PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Alexandra Scholze
    • 1
  • Igor W. Blau
    • 2
  • Martin Tepel
    • 1
  1. 1.Odense University Hospital, Department of Nephrology, Institute of Molecular MedicineUniversity of Southern DenmarkOdense CDenmark
  2. 2.Charité Campus Benjamin Franklin, Department of HematologyOncology and Transfusion MedicineBerlinGermany

Personalised recommendations